Posts Tagged ‘osteonecrosis’
Osteoporosis drug linked to very low risk of jaw disease
A drug, which is commonly prescribed to treat patients with osteoporosis, contributes to a very low risk of jaw disease, a study has revealed. The drug is associated with a very slightly elevated risk of the jaw condition osteonecrosis, which is a rare but potentially very serious condition. The study was funded by the National […]
Merck wins Fosamax case
Merck&Co have won a case involving the safety of their Fosamax drug. The case was launched by a woman, who claimed she suffered jaw problems after taking Merck&Co’s Fosamax drug, which is used to treat patients with osteoporosis. Louise Maley, from Indiana had been using the drug for eight years and claimed she suffered from […]
